ArticleClinical and experimental immunology2014

Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients.

A Busch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.